Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018, Article ID 6721530, 15 pages
https://doi.org/10.1155/2018/6721530
Research Article

Epigallocatechin-3-Gallate (EGCG) Promotes Autophagy-Dependent Survival via Influencing the Balance of mTOR-AMPK Pathways upon Endoplasmic Reticulum Stress

1Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary
2Pathobiochemistry Research Group of the Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary

Correspondence should be addressed to Orsolya Kapuy; uh.vinu-siewlemmes.dem@aylosro.yupak

Received 22 September 2017; Accepted 6 December 2017; Published 31 January 2018

Academic Editor: Maria C. Albertini

Copyright © 2018 Marianna Holczer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Isbrucker, J. Bausch, J. A. Edwards, and E. Wolz, “Safety studies on epigallocatechin gallate (EGCG) preparations. Part 1: genotoxicity,” Food and Chemical Toxicology, vol. 44, no. 5, pp. 626–635, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. A. Isbrucker, J. A. Edwards, E. Wolz, A. Davidovich, and J. Bausch, “Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies,” Food and Chemical Toxicology, vol. 44, no. 5, pp. 636–650, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. R. A. Isbrucker, J. A. Edwards, E. Wolz, A. Davidovich, and J. Bausch, “Safety studies on epigallocatechin gallate (EGCG) preparations. Part 3: teratogenicity and reproductive toxicity studies in rats,” Food and Chemical Toxicology, vol. 44, no. 5, pp. 651–661, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Bose, J. D. Lambert, J. Ju, K. R. Reuhl, S. A. Shapses, and C. S. Yang, “The major green tea polyphenol, (−)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice,” The Journal of Nutrition, vol. 138, no. 9, pp. 1677–1683, 2008. View at Google Scholar
  5. M. A. Potenza, F. L. Marasciulo, M. Tarquinio et al., “EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR,” American Journal of Physiology Endocrinology and Metabolism, vol. 292, no. 5, pp. E1378–E1387, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. A. Kim, G. Formoso, Y. Li et al., “Epigallocatechin gallate, a green tea polyphenol, mediates NO-dependent vasodilation using signaling pathways in vascular endothelium requiring reactive oxygen species and Fyn,” The Journal of Biological Chemistry, vol. 282, no. 18, pp. 13736–13745, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Vittal, Z. E. Selvanayagam, Y. Sun et al., “Gene expression changes induced by green tea polyphenol (−)-epigallocatechin-3-gallate in human bronchial epithelial 21BES cells analyzed by DNA microarray,” Molecular Cancer Therapeutics, vol. 3, no. 9, pp. 1091–1099, 2004. View at Google Scholar
  8. I. Sadowska-Bartosz and G. Bartosz, “Effect of antioxidants supplementation on aging and longevity,” BioMed Research International, vol. 2014, Article ID 404680, 17 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Zhang, G. Jie, J. Zhang, and B. Zhao, “Significant longevity-extending effects of EGCG on Caenorhabditis elegans under stress,” Free Radical Biology & Medicine, vol. 46, no. 3, pp. 414–421, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Niu, L. Na, R. Feng et al., “The phytochemical, EGCG, extends lifespan by reducing liver and kidney function damage and improving age-associated inflammation and oxidative stress in healthy rats,” Aging Cell, vol. 12, no. 6, pp. 1041–1049, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Aviv, J. Shaw, H. Gang, and L. A. Kirshenbaum, “Regulation of autophagy in the heart: “you only live twice”,” Antioxidants & Redox Signaling, vol. 14, no. 11, pp. 2245–2250, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Wirawan, T. Vanden Berghe, S. Lippens, P. Agostinis, and P. Vandenabeele, “Autophagy: for better or for worse,” Cell Research, vol. 22, no. 1, pp. 43–61, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Levine and G. Kroemer, “Autophagy in the pathogenesis of disease,” Cell, vol. 132, no. 1, pp. 27–42, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Ravikumar, S. Sarkar, J. E. Davies et al., “Regulation of mammalian autophagy in physiology and pathophysiology,” Physiological Reviews, vol. 90, no. 4, pp. 1383–1435, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Liu and B. Levine, “Autosis and autophagic cell death: the dark side of autophagy,” Cell Death and Differentiation, vol. 22, no. 3, pp. 367–376, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Hoyer-Hansen and M. Jaattela, “AMP-activated protein kinase: a universal regulator of autophagy?” Autophagy, vol. 3, no. 4, pp. 381–383, 2007. View at Publisher · View at Google Scholar
  17. J. Kim, M. Kundu, B. Viollet, and K. L. Guan, “AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1,” Nature Cell Biology, vol. 13, no. 2, pp. 132–141, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Watanabe, L. Wei, and J. Huang, “mTOR signaling, function, novel inhibitors, and therapeutic targets,” The Journal of Nuclear Medicine, vol. 52, no. 4, pp. 497–500, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Hay and N. Sonenberg, “Upstream and downstream of mTOR,” Genes and Development, vol. 18, no. 16, pp. 1926–1945, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Zoncu, A. Efeyan, and D. M. Sabatini, “mTOR: from growth signal integration to cancer, diabetes and ageing,” Nature Reviews Molecular Cell Biology, vol. 12, no. 1, pp. 21–35, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Alers, A. S. Loffler, S. Wesselborg, and B. Stork, “Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks,” Molecular and Cellular Biology, vol. 32, no. 1, pp. 2–11, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. R. J. Shaw, M. Kosmatka, N. Bardeesy et al., “The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 10, pp. 3329–3335, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. D. G. Hardie, “AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy,” Nature Reviews Molecular Cell Biology, vol. 8, no. 10, pp. 774–785, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. H. S. Kim, V. Montana, H. J. Jang, V. Parpura, and J. A. Kim, “Epigallocatechin gallate (EGCG) stimulates autophagy in vascular endothelial cells: a potential role for reducing lipid accumulation,” The Journal of Biological Chemistry, vol. 288, no. 31, pp. 22693–22705, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Zhong, J. Hu, W. Shu, B. Gao, and S. Xiong, “Epigallocatechin-3-gallate opposes HBV-induced incomplete autophagy by enhancing lysosomal acidification, which is unfavorable for HBV replication,” Cell Death & Disease, vol. 6, no. 5, article e1770, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. J. H. Lee, J. H. Moon, S. W. Kim et al., “EGCG-mediated autophagy flux has a neuroprotection effect via a class III histone deacetylase in primary neuron cells,” Oncotarget, vol. 6, no. 12, pp. 9701–9717, 2015. View at Publisher · View at Google Scholar
  27. C. H. Huang, S. J. Tsai, Y. J. Wang, M. H. Pan, J. Y. Kao, and T. D. Way, “EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells,” Molecular Nutrition & Food Research, vol. 53, no. 9, pp. 1156–1165, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. G. S. Van Aller, J. D. Carson, W. Tang et al., “Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor,” Biochemical and Biophysical Research Communications, vol. 406, no. 2, pp. 194–199, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Holczer, M. Marton, A. Kurucz, G. Banhegyi, and O. Kapuy, “A comprehensive systems biological study of autophagy-apoptosis crosstalk during endoplasmic reticulum stress,” BioMed Research International, vol. 2015, Article ID 319589, 12 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. O. Kapuy, P. K. Vinod, J. Mandl, and G. Banhegyi, “A cellular stress-directed bistable switch controls the crosstalk between autophagy and apoptosis,” Molecular BioSystems, vol. 9, no. 2, pp. 296–306, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. O. Kapuy, P. K. Vinod, and G. Banhegyi, “mTOR inhibition increases cell viability via autophagy induction during endoplasmic reticulum stress - an experimental and modeling study,” FEBS OpenBio, vol. 4, no. 1, pp. 704–713, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Karthikeyan, L. Harini, V. Krishnakumar, V. R. Kannan, K. Sundar, and T. Kathiresan, “Insights on the involvement of (−)-epigallocatechin gallate in ER stress-mediated apoptosis in age-related macular degeneration,” Apoptosis, vol. 22, no. 1, pp. 72–85, 2017. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Chomczynski and N. Sacchi, “The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on,” Nature Protocols, vol. 1, no. 2, pp. 581–585, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. J.-I. Ahn, J. K. Jeong, M.-J. Ko, H. J. Shin, J. H. Chung, and H.-S. Jeong, “High-concentration epigallocatechin gallate treatment causes endoplasmic reticulum stress-mediated cell death in HepG2 cells,” Genomics & Informatics, vol. 7, no. 2, pp. 97–106, 2009. View at Publisher · View at Google Scholar
  35. C. H. Yuan, C. T. Horng, C. F. Lee et al., “Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling,” Environmental Toxicology, vol. 32, no. 3, pp. 845–855, 2017. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Park, H. Jeong, M. N. Lee et al., “Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition,” Scientific Reports, vol. 6, no. 1, article 21772, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Holczer, G. Banhegyi, and O. Kapuy, “GADD34 keeps the mTOR pathway inactivated in endoplasmic reticulum stress related autophagy,” PLoS One, vol. 11, no. 12, article e0168359, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Malhi and R. J. Kaufman, “Endoplasmic reticulum stress in liver disease,” Journal of Hepatology, vol. 54, no. 4, pp. 795–809, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Walter and D. Ron, “The unfolded protein response: from stress pathway to homeostatic regulation,” Science, vol. 334, no. 6059, pp. 1081–1086, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Hyrskyluoto, S. Reijonen, J. Kivinen, D. Lindholm, and L. Korhonen, “GADD34 mediates cytoprotective autophagy in mutant huntingtin expressing cells via the mTOR pathway,” Experimental Cell Research, vol. 318, no. 1, pp. 33–42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. G. S. Hotamisligil, “Endoplasmic reticulum stress and the inflammatory basis of metabolic disease,” Cell, vol. 140, no. 6, pp. 900–917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. F. Prattichizzo, V. De Nigris, L. La Sala, A. D. Procopio, F. Olivieri, and A. Ceriello, ““Inflammaging” as a druggable target: a senescence-associated secretory phenotype-centered view of type 2 diabetes,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 1810327, 10 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Lindholm, H. Wootz, and L. Korhonen, “ER stress and neurodegenerative diseases,” Cell Death and Differentiation, vol. 13, no. 3, pp. 385–392, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. H. S. Kim, M. J. Quon, and J. A. Kim, “New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate,” Redox Biology, vol. 2, pp. 187–195, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Revesz, A. Tutto, P. Szelenyi, and L. Konta, “Tea flavan-3-ols as modulating factors in endoplasmic reticulum function,” Nutrition Research, vol. 31, no. 10, pp. 731–740, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Gamberucci, L. Konta, A. Colucci et al., “Green tea flavonols inhibit glucosidase II,” Biochemical Pharmacology, vol. 72, no. 5, pp. 640–646, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. P. Szelenyi, K. Revesz, L. Konta et al., “Inhibition of microsomal cortisol production by (−)-epigallocatechin-3-gallate through a redox shift in the endoplasmic reticulum—a potential new target for treating obesity-related diseases,” BioFactors, vol. 39, no. 5, pp. 534–541, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. K. Revesz, A. Tutto, E. Margittai et al., “Glucuronide transport across the endoplasmic reticulum membrane is inhibited by epigallocatechin gallate and other green tea polyphenols,” The International Journal of Biochemistry & Cell Biology, vol. 39, no. 5, pp. 922–930, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Csala, E. Margittai, S. Senesi et al., “Inhibition of hepatic glucose 6-phosphatase system by the green tea flavanol epigallocatechin gallate,” FEBS Letters, vol. 581, no. 8, pp. 1693–1698, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. L. G. Xiong, Y. J. Chen, J. W. Tong, Y. S. Gong, J. A. Huang, and Z. H. Liu, “Epigallocatechin-3-gallate promotes healthy lifespan through mitohormesis during early-to-mid adulthood in Caenorhabditis elegans,” Redox Biology, vol. 14, pp. 305–315, 2018. View at Publisher · View at Google Scholar